Forma Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on May 14, 2021
Forma Therapeutics Holdings (Nasdaq: FMTX) will release its Q1 2021 financial results on May 14, 2021. The management plans to host a conference call at 8 a.m. ET on the same day to discuss these results and provide a business update. Investors can join the call by dialing specific numbers or through a live webcast on Forma's website.
The company is dedicated to developing innovative therapies for rare hematologic diseases and cancers, aiming to significantly improve patient outcomes.
- Focus on research and development of novel therapeutics for rare diseases and cancers.
- Broad proprietary portfolio of programs with potential patient benefits.
- None.
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that it will release first quarter 2021 financial results on Friday, May 14, 2021. Forma management will host an investment community conference call at 8 a.m. Eastern Time, on May 14, 2021, to discuss these financial results and provide a business update.
Investors may participate by dialing (833) 301-1146 in the U.S. or Canada, or (914) 987-7386 internationally, and by referring to Conference ID 8597396. A live webcast of the conference call will be available in the “News & Investors” section of Forma’s website at www.formatherapeutics.com.
About Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005409/en/
FAQ
When will Forma Therapeutics release its Q1 2021 financial results?
What time is the conference call for Forma Therapeutics Q1 results?
How can I participate in the Forma Therapeutics conference call?
What is the focus of Forma Therapeutics?
